Literature DB >> 2645122

Hypoglycemia associated with renal failure.

R Arem1.   

Abstract

Hypoglycemia associated with renal failure is more common than generally thought. Its occurrence is often a marker of multisystem failure and has an ominous prognostic implication. Its pathogenesis is frequently complex and involves one or several mechanisms. In the evaluation of uremic hypoglycemia, the first step should be the exclusion of obvious causes such as insulin, oral hypoglycemic agent therapy, and the use of drugs known to cause hypoglycemia. Propranolol, salicylates, and disopyramide are among the most commonly implicated agents. Additional triggering events are alcohol consumption, sepsis, chronic malnutrition, acute caloric deprivation, concomitant liver disease, congestive heart failure, and an associated endocrine deficiency. When no obvious cause can be demonstrated, the hypoglycemia is referred to as spontaneous. Spontaneous uremic hypoglycemia has been attributed to deficiency of precursors of gluconeogenesis, that is, alanine, deficient gluconeogenesis, impaired glycogenolysis, diminished renal gluconeogenesis and impaired renal insulin degradation and clearance, poor nutrition, and, in a few cases, deficiency in an immediate counterregulatory hormone such as catecholamine and glucagon. However, the mechanism(s) seems to differ from one patient to the other. Dialysis also predisposes to hypoglycemia in uremia, possibly because of the chronic state of malnutrition. Postdialysis hypoglycemia is secondary to glucose-induced hyperinsulinemia, which is caused by the high glucose content in the dialysate. In uremic hypoglycemia, neuroglycopenic manifestations predominate because of frequent autonomic nervous system dysfunction and lack of catecholamine release in response to hypoglycemia. Its severity and duration are variable. Hypoglycemia should be suspected in any patient with renal failure who exhibits any change in mental or neurologic status. Detection of hypoglycemia should rely on frequent and careful glucose determinations in any patient with uremia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645122

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  32 in total

1.  Evaluation of patients admitted with hypoglycaemia to a teaching hospital in Central Anatolia.

Authors:  M Güven; F Bayram; K Güven; F Kelestimur
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

2.  Postgastric bypass hypoglycaemia in a patient with end-stage renal disease: a diagnostic and management pitfall.

Authors:  Sameen Khalid; Anika Bilal; F N U Asad-Ur-Rahman; Richard Pratley
Journal:  BMJ Case Rep       Date:  2017-06-15

Review 3.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

4.  Severe hypoglycemia in a nondiabetic patient leading to acute respiratory failure.

Authors:  Muhammad Ahsan Baig; Shaukat Ali; Javeria Rasheed; Michael Bergman; Vladimir Privman
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

Review 5.  How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting.

Authors:  Kristen Kulasa; Patricia Juang
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

6.  The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD.

Authors:  Bayan Mesmar; Megan Kristan; Medha Satyarengga; Elizabeth M Lamos; Rana Malek; Kashif M Munir
Journal:  CEN Case Rep       Date:  2020-04-09

Review 7.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

8.  Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine.

Authors:  M Stumvoll; U Chintalapudi; G Perriello; S Welle; O Gutierrez; J Gerich
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Management of diabetes in dialysis patients.

Authors:  Mark E Williams
Journal:  Curr Diab Rep       Date:  2009-12       Impact factor: 4.810

10.  Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure.

Authors:  Ch Sampanis
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.